These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 12895272)

  • 1. Solution structure of a novel T-cell adhesion inhibitor derived from the fragment of ICAM-1 receptor: cyclo(1,8)-Cys-Pro-Arg-Gly-Gly-Ser-Val-Cys.
    Tejo BA; Siahaan TJ
    Biopolymers; 2009 Aug; 91(8):633-41. PubMed ID: 19330816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaustive Conformational Sampling of Complex Fused Ring Macrocycles Using Inverse Kinematics.
    Coutsias EA; Lexa KW; Wester MJ; Pollock SN; Jacobson MP
    J Chem Theory Comput; 2016 Sep; 12(9):4674-87. PubMed ID: 27447193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor.
    Larson RS; Brown DC; Ye C; Hjelle B
    J Virol; 2005 Jun; 79(12):7319-26. PubMed ID: 15919886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR solution structure of a potent cyclic nonapeptide inhibitor of ICAM-1-mediated leukocyte adhesion produced by homologous amino acid substitution.
    Sillerud LO; Burks EJ; Brown WM; Brown DC; Larson RS
    J Pept Res; 2004 Oct; 64(4):127-40. PubMed ID: 15357668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel cyclic peptide inhibits intercellular adhesion molecule-1-mediated cell aggregation.
    Shannon JP; Silva MV; Brown DC; Larson RS
    J Pept Res; 2001 Aug; 58(2):140-50. PubMed ID: 11532073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Ca2+ binding cyclic peptide derived from the alpha-subunit of LFA-1: inhibitor of ICAM-1/LFA-1-mediated T-cell adhesion.
    Jois SD; Tibbetts SA; Chan MA; Benedict SH; Siahaan TJ
    J Pept Res; 1999 Jan; 53(1):18-29. PubMed ID: 10195438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and ICAM-1-docking properties of a cyclic peptide from the I-domain of LFA-1: an inhibitor of ICAM-1/LFA- 1-mediated T-cell adhesion.
    Xu CR; Yusuf-Makagiansar H; Hu Y; Jois SD; Siahaan TJ
    J Biomol Struct Dyn; 2002 Apr; 19(5):789-99. PubMed ID: 11922836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A peptide derived from LFA-1 protein that modulates T-cell adhesion binds to soluble ICAM-1 protein.
    Jois SD; Teruna TJ
    J Biomol Struct Dyn; 2003 Apr; 20(5):635-44. PubMed ID: 12643766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors.
    Anderson ME; Siahaan TJ
    Peptides; 2003 Mar; 24(3):487-501. PubMed ID: 12732350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR Spectroscopy in the Conformational Analysis of Peptides: An Overview.
    Vincenzi M; Mercurio FA; Leone M
    Curr Med Chem; 2021; 28(14):2729-2782. PubMed ID: 32614739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR-derived model of interconverting conformations of an ICAM-1 inhibitory cyclic nonapeptide.
    Sillerud LO; Burks EJ; Wester MJ; Brown DC; Vijayan S; Larson RS
    J Pept Res; 2003 Sep; 62(3):97-116. PubMed ID: 12895272
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.